| Impact of dabigatran on a large panel of routine or specific coagulation assays J Douxfils, F Mullier, S Robert, C Chatelain, B Chatelain, JM Dogné Thrombosis and haemostasis 107 (05), 985-997, 2012 | 471 | 2012 |
| Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians J Douxfils, W Ageno, CM Samama, S Lessire, H Ten Cate, P Verhamme, ... Journal of Thrombosis and Haemostasis 16 (2), 209-219, 2018 | 396 | 2018 |
| International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants RC Gosselin, DM Adcock, SM Bates, J Douxfils, EJ Favaloro, ... Thrombosis and haemostasis 118 (03), 437-450, 2018 | 390 | 2018 |
| Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature J Douxfils, F Mullier, C Loosen, C Chatelain, B Chatelain, JM Dogné Thrombosis research 130 (6), 956-966, 2012 | 298 | 2012 |
| Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide J Douxfils, C Chatelain, B Chatelain, JM Dogné, F Mullier Thrombosis and haemostasis 110 (08), 283-294, 2013 | 268 | 2013 |
| Association between BCR-ABL tyrosine kinase inhibitors for chronic myeloid leukemia and cardiovascular events, major molecular response, and overall survival: a systematic … J Douxfils, H Haguet, F Mullier, C Chatelain, C Graux, JM Dogne JAMA oncology 2 (5), 625-632, 2016 | 204 | 2016 |
| Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban J Douxfils, A Tamigniau, B Chatelain, C Chatelain, P Wallemacq, F Mullier, ... Thromb Haemost 110 (3), 2013 | 187 | 2013 |
| 2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants J Douxfils, DM Adcock, SM Bates, EJ Favaloro, I Gouin-Thibault, ... Thrombosis and haemostasis 121 (08), 1008-1020, 2021 | 176 | 2021 |
| Antibody titres decline 3-month post-vaccination with BNT162b2 J Favresse, JL Bayart, F Mullier, M Elsen, C Eucher, SV Eeckhoudt, T Roy, ... Emerg Microbes Infect. 10 (1), 1495-1498, 2021 | 171 | 2021 |
| Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate J Douxfils, JM Dogné, F Mullier, B Chatelain, Y Rönquist-Nii, ... Thromb Haemost 110 (3), 543-549, 2013 | 144 | 2013 |
| Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers JL Bayart, J Douxfils, C Gillot, C David, F Mullier, M Elsen, C Eucher, ... Vaccines 9 (10), 1092, 2021 | 126 | 2021 |
| Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody M Tré-Hardy, A Wilmet, I Beukinga, JM Dogné, J Douxfils, L Blairon Clinical Chemistry and Laboratory Medicine (CCLM) 58 (8), 1357-1364, 2020 | 126 | 2020 |
| Perioperative management of patients on direct oral anticoagulants V Dubois, AS Dincq, J Douxfils, B Ickx, CM Samama, JM Dogné, ... Thrombosis Journal 15, 1-17, 2017 | 125 | 2017 |
| Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all‐cause mortality: a systematic review and meta‐analysis of … J Douxfils, F Buckinx, F Mullier, V Minet, V Rabenda, JY Reginster, ... Journal of the American Heart Association 3 (3), e000515, 2014 | 125 | 2014 |
| Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters J Douxfils, C Klipping, I Duijkers, V Kinet, M Mawet, C Maillard, M Jost, ... Contraception 102 (6), 396-402, 2020 | 116 | 2020 |
| Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies M Tré‐Hardy, A Wilmet, I Beukinga, J Favresse, JM Dogné, J Douxfils, ... Journal of medical virology 93 (2), 803-811, 2021 | 115 | 2021 |
| Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies J Favresse, C Eucher, M Elsen, M Tré-Hardy, JM Dogné, J Douxfils Clinical chemistry 66 (8), 1104-1106, 2020 | 115 | 2020 |
| Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk L Morimont, H Haguet, JM Dogné, U Gaspard, J Douxfils Frontiers in endocrinology 12, 769187, 2021 | 111 | 2021 |
| Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study AS Larock, F Mullier, AL Sennesael, J Douxfils, B Devalet, C Chatelain, ... Annals of Pharmacotherapy 48 (10), 1258-1268, 2014 | 110 | 2014 |
| Laboratory assessment of direct oral anticoagulants J Douxfils, RC Gosselin Seminars in thrombosis and hemostasis 43 (03), 277-290, 2017 | 100 | 2017 |
Dogne Jean-MichelProfessor at University of Namurunamur.be의 이메일 확인됨
